Targeted Resequencing and Systematic In Vivo Functional Testing Identifies Rare Variants in MEIS1 as Significant Contributors to Restless Legs Syndrome
Eva C. Schulte(Argonne National Laboratory), Juliane Winkelmann(Helmholtz Zentrum München), Alexander Zimprich(Ludwig-Maximilians-Universität München), Nicholas Katsanis(Io Therapeutics (United States)), Birgit Högl(Innsbruck Medical University), Bertram Müller‐Myhsok(Max Planck Institute of Psychiatry), Ingo Fietze(Humboldt-Universität zu Berlin), Birgit Frauscher(Montreal Neurological Institute and Hospital), Erik Tilch(Helmholtz Munich), Peter Lichtner(The University of Melbourne), Perciliz L. Tan(Johns Hopkins University), Klaus Berger(University of Münster), Magdolna Hornyak(University Medical Center Freiburg), Christian Gieger(Helmholtz Zentrum München), Annette Peters(Zimmer Biomet (Netherlands)), Cornelius G. Bachmann(Paracelsus-Kliniken), Claudia Trenkwalder(Paracelsus Elena Klinik Kassel), Thomas Meitinger(Helmholtz Zentrum München), Wolfgang H. Oertel(Philipps University of Marburg), Maria Kousi
Cited by 66
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k